Rohit Jadhav

Dr. Rohit Jadhav

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2022 in Nature
Verified
Journal Article
Closed access
PDF file
MHMasao Hashimoto
Masao Hashimoto
KAKoichi Araki
Koichi Araki
MCMaria A. Cardenas
Maria A. Cardenas
PLPeng Li
Peng Li
RJRohit Jadhav
Rohit Jadhav
RARafi Ahmed
Rafi Ahmed

31 December 2012 in The Prostate
Verified
Journal Article
Closed access
PDF file
CCChun-Liang Chen
Chun-Liang Chen
DMDevalingam Mahalingam
Devalingam Mahalingam
POPawel A. Osmulski
Pawel A. Osmulski
RJRohit Jadhav
Rohit Jadhav
CWChiou‐Miin Wang
Chiou‐Miin Wang
THTim H.-M. Huang
Tim H.-M. Huang

12 December 2022 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
HZHuimin Zhang
Huimin Zhang
RJRohit Jadhav
Rohit Jadhav
WCWenqiang Cao
Wenqiang Cao
IGIsabel N. Goronzy
Isabel N. Goronzy
TZTuantuan V. Zhao
Tuantuan V. Zhao
JGJörg J. Goronzy
Jörg J. Goronzy

15 November 2012 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
DSDeepali V. Sawant
Deepali V. Sawant
SSSarita Sehra
Sarita Sehra
ENEvelyn T. Nguyen
Evelyn T. Nguyen
RJRohit Jadhav
Rohit Jadhav
KEKate Englert
Kate Englert
ADAlexander L. Dent
Alexander L. Dent
The transcriptional repressor Bcl6 is a critical arbiter of Th cell fate, promoting the follicular Th lineage while repressing other Th cell lineages. Bcl6-deficient (Bcl6−/−) mice develop a spontaneous and severe Th2-type inflammatory disease, thus warranting assessment of Bcl6 in regulatory T cell (Treg) function. Bcl6−/− Tregs were competent at suppressing T cell proliferation in vitro and Th1-type colitogenic T cell responses in vivo. In contrast, Bcl6−/− Tregs strongly exacerbated lung inflammation in a model of allergic airway disease and promoted higher Th2 responses, including systemic upregulation of microRNA-21. Further, Bcl6−/− Tregs were selectively impaired at controlling Th2 responses, but not Th1 and Th17 responses, in mixed chimeras of Bcl6−/− bone marrow with Foxp3−/− bone marrow. Bcl6−/− Tregs displayed increased levels of the Th2 transcription factor Gata3 and other Th2 and Treg genes. Bcl6 potently repressed Gata3 transcriptional transactivation, providing a mechanism for the increased expression of Th2 genes by Bcl6−/− Tregs. Gata3 has a critical role in regulating Foxp3 expression and functional fitness of Tregs; however, the signal that regulates Gata3 and restricts its transactivation of Th2 cytokines in Tregs has remained unexplored. Our results identify Bcl6 as an essential transcription factor regulating Gata3 activity in Tregs. Thus, Bcl6 represents a crucial regulatory layer in the Treg functional program that is required for specific suppression of Gata3 and Th2 effector responses by Tregs.

10 February 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZYZhongde Ye
Zhongde Ye
YSYi Shen
Yi Shen
KJKe Jin
Ke Jin
JQJingtao Qiu
Jingtao Qiu
BHBin Hu
Bin Hu
JGJörg J. Goronzy
Jörg J. Goronzy
Rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are two distinct autoimmune diseases that manifest with chronic synovial inflammation. Here, we show that CD4+ T cells from patients with RA and PsA have increased expression of the pore-forming calcium channel component ORAI3, thereby increasing the activity of the arachidonic acid-regulated calcium-selective (ARC) channel and making T cells sensitive to arachidonic acid. A similar increase does not occur in T cells from patients with systemic lupus erythematosus. Increased ORAI3 transcription in RA and PsA T cells is caused by reduced IKAROS expression, a transcriptional repressor of the ORAI3 promoter. Stimulation of the ARC channel with arachidonic acid induces not only a calcium influx, but also the phosphorylation of components of the T cell receptor signaling cascade. In a human synovium chimeric mouse model, silencing ORAI3 expression in adoptively transferred T cells from patients with RA attenuates tissue inflammation, while adoptive transfer of T cells from healthy individuals with reduced expression of IKAROS induces synovitis. We propose that increased ARC activity due to reduced IKAROS expression makes T cells more responsive and contributes to chronic inflammation in RA and PsA.

3 August 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZYZhongde Ye
Zhongde Ye
GLGuangjin Li
Guangjin Li
CKChulwoo Kim
Chulwoo Kim
BHBin Hu
Bin Hu
RJRohit Jadhav
Rohit Jadhav
JGJörg J. Goronzy
Jörg J. Goronzy
MicroRNAs have emerged as key regulators in T cell development, activation, and differentiation, with miR-181a having a prominent function. By targeting several signaling pathways, miR-181a is an important rheostat controlling T cell receptor (TCR) activation thresholds in thymic selection as well as peripheral T cell responses. A decline in miR-181a expression, due to reduced transcription of pri-miR-181a, accounts for T cell activation defects that occur with older age. Here we examine the transcriptional regulation of miR-181a expression and find a putative pri-miR-181a enhancer around position 198,904,300 on chromosome 1, which is regulated by a transcription factor complex including YY1. The decline in miR-181a expression correlates with reduced transcription of YY1 in older individuals. Partial silencing of YY1 in T cells from young individuals reproduces the signaling defects seen in older T cells. In conclusion, YY1 controls TCR signaling by upregulating miR-181a and dampening negative feedback loops mediated by miR-181a targets.